Medicare proposes restricting coverage of Alzheimer’s drug to clinical trials

Medicare officials announced that a new Alzheimer’s drug will be covered only for patients participating in approved clinical trials. In a preliminary decision, the Centers for Medicare and Medicaid Services (“CMS”) said on Tuesday that the federal health insurance program should cover the Alzheimer’s drug ‘Aduhelm’ only for use in “CMS-approved randomized controlled trials” and … Read more